Home/Medicines/Cabergoline
All medicines

Cabergoline

Prescription
Dopamine D2 agonist (ergot derivative)
Last reviewed 19 Apr 2026 · PetCare.AI Editorial Team
Species
Dog, Cat
Brands
3 available
Formulations
2

Mechanism of action

Stimulates dopamine D2 receptors in the anterior pituitary, potently inhibiting prolactin secretion; used to terminate pseudopregnancy and suppress lactation

At a glance

Class
Dopamine D2 agonist (ergot derivative)
Schedule
Prescription
Storage
Store below 25°C, protect from light

Dosing

🐕

Dog

Pseudopregnancy / Lactation suppression / Pregnancy termination (with cloprostenol)
Dose
1.65–5 mcg/kg
Route
PO
Frequency
SID
Max dose
250 mcg
Duration: 5–10 days for pseudopregnancy; 7–10 days combined protocol for pregnancy termination
🐈

Cat

Pseudopregnancy / Lactation suppression
Dose
5 mcg/kg
Route
PO
Frequency
SID
Max dose
50 mcg
Duration: 5–7 days

Formulations

💊

Tablet — 1

Strength
0.5mg
Available in India
🧴

Oral solution — 1

Strength
50mcg/mL (veterinary)

Storage

Store below 25°C, protect from light

Safety

Absolute contraindications — do not use

  • Pregnancy (first trimester — teratogenic risk)
    Use for pregnancy termination only under veterinary supervision with confirmed protocol

Use with caution

  • Hepatic insufficiency
    Hepatically metabolized

Adverse effects

Common
Vomiting (first dose)
Inappetence
Transient lethargy
Serious
Hypotension (rare)

Monitoring parameters

Lactation/mammary gland regressionNesting behavior resolution

Interactions

No documented interactions.

Brands

International

Galastop
Ceva

India

Caberlin
Sun Pharma
Cabgolin
Cadila

FAQs

Frequently asked questions

What is Cabergoline?
Cabergoline is a dopamine d2 agonist (ergot derivative) used in pets. Stimulates dopamine D2 receptors in the anterior pituitary, potently inhibiting prolactin secretion; used to terminate pseudopregnancy and suppress lactation
What is Cabergoline used for in pets?
Cabergoline is used in veterinary medicine for: Pseudopregnancy / Lactation suppression / Pregnancy termination (with cloprostenol); Pseudopregnancy / Lactation suppression.
What is the Cabergoline dose for dogs?
For dogs, Cabergoline is typically dosed as follows — Pseudopregnancy / Lactation suppression / Pregnancy termination (with cloprostenol): 1.65–5 mcg/kg PO SID. Always consult your veterinarian for a dose tailored to your pet's weight, age, and condition.
What is the Cabergoline dose for cats?
For cats, Cabergoline is typically dosed as follows — Pseudopregnancy / Lactation suppression: 5 mcg/kg PO SID. Always consult your veterinarian for a dose tailored to your pet's weight, age, and condition.
What are the side effects of Cabergoline?
Common: Vomiting (first dose), Inappetence, Transient lethargy. Serious (call your vet immediately): Hypotension (rare).
Does Cabergoline need a prescription?
Yes. Cabergoline is a prescription medication and should only be administered under veterinary supervision.
When should Cabergoline not be used?
Do not use Cabergoline if: Pregnancy (first trimester — teratogenic risk).

References

References

Textbooks & handbooks

  • Plumb, D.C. Plumb's Veterinary Drug Handbook. 10th ed., Wiley-Blackwell, 2023.
  • Vail, D.M., Thamm, D.H., & Liptak, J.M. (eds.). Withrow & MacEwen's Small Animal Clinical Oncology. 6th ed., Saunders/Elsevier, 2020.
  • Riviere, J.E., & Papich, M.G. (eds.). Veterinary Pharmacology and Therapeutics. 10th ed., Wiley-Blackwell, 2018.
  • National Research Council. Nutrient Requirements of Dogs and Cats. National Academies Press, Washington DC, 2006.
  • The Merck Veterinary Manual. Merck & Co., Online edition. https://www.merckvetmanual.com/

Clinical guidelines & consensus

  • Fletcher, D.J., Boller, M., Brainard, B.M., et al. "RECOVER Evidence and Knowledge Gap Analysis on Veterinary CPR." Journal of Veterinary Emergency and Critical Care, 2012;22(S1):S102–S131.
  • American Animal Hospital Association. 2018 AAHA Diabetes Management Guidelines for Dogs and Cats. AAHA Press.

Journals & peer-reviewed studies

  • Hogan, D.F., Fox, P.R., Jacob, K., et al. "Secondary prevention of cardiogenic arterial thromboembolism in the cat: The FAT CAT study." Journal of Veterinary Cardiology, 2015;17(Suppl 1):S306–S317.
  • Boswood, A., Häggström, J., Gordon, S.G., et al. "Effect of Pimobendan in Dogs with Preclinical Myxomatous Mitral Valve Disease and Cardiomegaly: The EPIC Study — A Randomized Clinical Trial." Journal of Veterinary Internal Medicine, 2016;30(6):1765–1779.
  • ASPCA Animal Poison Control Center. Toxicology and Poison Management Guidelines. American Society for the Prevention of Cruelty to Animals. https://www.aspca.org/pet-care/animal-poison-control

Regulatory & approvals

  • Central Drugs Standard Control Organisation (CDSCO), Government of India. Veterinary Drug Approval Registry, 1969–2026. Directorate General of Health Services. https://cdsco.gov.in/

Databases

  • Washington State University, College of Veterinary Medicine. Veterinary Clinical Pharmacology Laboratory (VCPL) — MDR1 Multidrug Sensitivity Database. https://vcpl.vetmed.wsu.edu/
Educational reference only
This information is provided for educational purposes and is not a substitute for professional veterinary advice, diagnosis, or treatment. Always consult a qualified veterinarian before administering any medication to your pet. Find a vet near you →